Finance Aeglea BioTherapeutics Stock Surges Over 400% TodayJune 22, 20230 Aeglea BioTherapeutics Inc (NASDAQ: AGLE) has acquired Spyre Therapeutics, a privately-held biotechnology firm targeted on creating antibody therapeutics for inflammatory bowel illness.As a…